Identification of novel mutations in LprG (rv1411c), rv0521, rv3630, rv0010c, ppsC, cyp128 associated with pyrazinoic acid/pyrazinamide resistance in Mycobacterium tuberculosis
There is currently considerable interest in understanding the mechanisms of action of pyrazinamide (PZA), a critical frontline tuberculosis (TB) drug that plays a unique role in shortening TB therapy due to its unique activity against Mycobacterium tuberculosis persisters. PZA is a prodrug that is converted to its active form pyrazoic acid (POA) by PncA enzyme. However, the mechanisms of action and resistance of PZA are complex and are not well understood. So far, pncA, rpsA, panD, and clpC1 are known to be involved in PZA resistance, however, we still find some PZA/POA-resistant strains still do not have any mutations in the above known genes involved in PZA resistance, indicating that new mechanisms of PZA/POA resistance must exist. Here, to identify possible new mechanisms of PZA resistance, we characterized 109 POA-resistant mutants and found that most (101/109=93%) of POA-resistant mutants had panD mutations. Among the 8 POA-resistant mutants that did not have panD mutations, 4 had the same clpC1 mutation (S91G), while the remaining 4 did not have any mutations in the known PZA resistance genes. Whole genome sequencing of the 4 POA-resistant mutants revealed that they all had the same two mutations rv1411c (Lipoprotein LprG C672T change leading to W224STOP) and rv0521 (Methyltransferase, C295T causing amino acid substitution R99W). However, one strain (3G1) had only the two identical mutations in LprG (rv1411c) and rv0521 while the remaining 3 mutants had additional low percentage of heterogeneous mutations in rv3630 (hypothetical protein), rv0010c (hypothetical protein), ppsC (phenolpthiocerol synthesis type-I polyketide synthase C) and cyp128 (cytochrome P450 128). LprG-Rv1410 participates in triacylglyceride (TAG) transport in M. tuberculosis and loss of its function leads to intracellular TAG accumulation, and is critical for regulating bacterial growth and metabolism during carbon starvation and infection. The finding that all 4 POA-resistant mutants have the same W224Stop mutation in LprG suggests that the non-functional LprG may lead to higher TAG accumulation and thus causing higher metabolism, which is known to antagonize PZA/POA activity. This provides a plausible explanation for loss of function mutation in LprG being a likely cause for PZA/POA resistance. Our findings shed new light on the mechanisms of action and resistance of PZA/POA. Future studies are needed to address the role of the identified mutations in PZA resistance and how they might be involved in the action of PZA in M. tuberculosis.
- Downloaded 277 times
- Download rankings, all-time:
- Site-wide: 102,958
- In microbiology: 7,435
- Year to date:
- Site-wide: 108,784
- Since beginning of last month:
- Site-wide: 96,280
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!